Bosco, F.; Guarnieri, L.; Rania, V.; Palma, E.; Citraro, R.; Corasaniti, M.T.; Leo, A.; De Sarro, G.
Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence. Int. J. Mol. Sci. 2023, 24, 12639.
https://doi.org/10.3390/ijms241612639
AMA Style
Bosco F, Guarnieri L, Rania V, Palma E, Citraro R, Corasaniti MT, Leo A, De Sarro G.
Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence. International Journal of Molecular Sciences. 2023; 24(16):12639.
https://doi.org/10.3390/ijms241612639
Chicago/Turabian Style
Bosco, Francesca, Lorenza Guarnieri, Vincenzo Rania, Ernesto Palma, Rita Citraro, Maria Tiziana Corasaniti, Antonio Leo, and Giovambattista De Sarro.
2023. "Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence" International Journal of Molecular Sciences 24, no. 16: 12639.
https://doi.org/10.3390/ijms241612639
APA Style
Bosco, F., Guarnieri, L., Rania, V., Palma, E., Citraro, R., Corasaniti, M. T., Leo, A., & De Sarro, G.
(2023). Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence. International Journal of Molecular Sciences, 24(16), 12639.
https://doi.org/10.3390/ijms241612639
